FY2025 · period end Dec '25 · from the 10-K filed Feb 25, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $17.36B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-235480 | May 20, 2026 | May 22, 2026 | May 22, 2026 11:30 UTC | EDGAR |
| 8-K | 0001193125-26-233402 | May 18, 2026 | May 21, 2026 | May 21, 2026 11:30 UTC | EDGAR |
| 10-Q | 0001193125-26-211992 | Mar 31, 2026 | May 7, 2026 | May 7, 2026 20:17 UTC | EDGAR |
| 8-K | 0001193125-26-183643 | Apr 27, 2026 | Apr 28, 2026 | Apr 28, 2026 12:15 UTC | EDGAR |
| 8-K | 0001193125-26-175197 | Apr 22, 2026 | Apr 24, 2026 | Apr 24, 2026 12:15 UTC | EDGAR |
| 8-K | 0001193125-26-131809 | Mar 26, 2026 | Mar 30, 2026 | Mar 30, 2026 21:30 UTC | EDGAR |
| 8-K | 0001193125-26-097674 | Mar 9, 2026 | Mar 9, 2026 | Mar 9, 2026 12:46 UTC | EDGAR |
| 8-K | 0001193125-26-073545 | Feb 25, 2026 | Feb 26, 2026 | Feb 26, 2026 13:15 UTC | EDGAR |
Direct links to SEC EDGAR. UHS has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Cash Provided by (Used in) Operating Activities·Q1 2018
Major restatementwas$364.1M
Revised up in a 10-Q. Any P/OCF built on the original was 11.2% too high.
Net Cash Provided by (Used in) Operating Activities·Q1 2019
Major restatementwas$390.9M
Revised up in a 10-Q. Any P/OCF built on the original was 9.5% too high.
Revenue, Net (Deprecated 2018-01-31)·Q3 2011
Major restatementwas$1.8B
Revised down in a 10-K. Any P/S built on the original was 11.2% too low.
Revenue, Net (Deprecated 2018-01-31)·Q2 2011
Major restatementwas$1.9B
Revised down in a 10-K. Any P/S built on the original was 11.2% too low.
Revenue, Net (Deprecated 2018-01-31)·Q1 2011
Notable restatementwas$1.9B
Revised down in a 10-K. Any P/S built on the original was 10.9% too low.
Revenue, Net (Deprecated 2018-01-31)·3 months to Dec 2011
Notable restatementwas$1.8B
Revised down in a 10-K. Any P/S built on the original was 10.6% too low.
UHS is not the only one.
See every restatement we've found across the market — or get an alert the next time UHS revises a number.
Restatements are detected by comparing every vintage of a fact across all of UNIVERSAL HEALTH SERVICES INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows UHS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling UNIVERSAL HEALTH SERVICES INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on UHS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on UHS and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $14.28B |
| $13.40B |
| $12.64B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B |
|---|
| Net Income | $1.49B | $1.14B | $0.72B | $0.68B | $0.99B |
|---|
| EPS (Diluted) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $7.34B | $6.75B | $6.20B | $5.97B | $6.19B |
| Cash & Equivalents | $0.14B | $0.22B | $0.12B | $0.20B | $0.18B |
| Total Debt | $4.77B | $4.52B | $4.93B | $4.83B | $4.21B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.86B | $2.07B | $1.27B | $1.00B | $0.88B |
| Capital Expenditures | $1.02B | $0.94B | $0.74B | $0.73B | $0.86B |
| Free Cash Flow | $0.85B | $1.12B | $0.52B | $0.26B | $0.03B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 21.1% | 17.6% | 11.8% | 11.1% | 15.7% |
| Return on Assets | 9.9% | 8.0% | 5.2% | 5.1% | 7.5% |
| Debt / Equity | 0.65× | 0.67× | 0.80× | 0.81× | 0.68× |
